Treatment Options for Pediatric Migraines
For pediatric migraine treatment, ibuprofen (7.5-10 mg/kg) and acetaminophen (15 mg/kg) should be used as first-line acute treatments, with triptans (particularly sumatriptan nasal spray) recommended for moderate to severe headaches or when NSAIDs fail to provide relief. 1
Acute Treatment Algorithm
First-Line Options:
- Ibuprofen (7.5-10 mg/kg): Safe and effective for mild to moderate pain
- Acetaminophen (15 mg/kg): Alternative for patients who cannot tolerate NSAIDs
Second-Line Options (for moderate to severe headaches):
- Sumatriptan nasal spray: FDA-approved for children as young as 6 years
- 5 mg for younger children
- 20 mg for adolescents
- Other oral triptans for adolescents:
- Zolmitriptan nasal
- Rizatriptan orally disintegrating tablets (ODT)
- Almotriptan oral
- Sumatriptan/naproxen combination
Treatment Pearls:
- Treat early in the attack for best results 1
- If one triptan is ineffective, try another or a NSAID-triptan combination 1
- For rapidly escalating headaches, use non-oral triptans (nasal formulations) 1
- For headaches with nausea/vomiting, add an anti-emetic or use non-oral medication 1
Caution: Sumatriptan is not recommended for patients under 18 years according to FDA labeling due to limited safety data, though clinical practice guidelines support its use in adolescents 2
Preventive Treatment
Consider preventive treatment for children with:
- Frequent headaches (>1 per week)
- Disabling headaches affecting quality of life
- Medication overuse headaches 1
First-Line Preventive Options:
- Amitriptyline with cognitive behavioral therapy: Combination therapy shows better efficacy than medication alone 1, 3
- Topiramate: Effective but requires monitoring for side effects 1, 3
- Propranolol: Consider in patients without asthma 1, 3
Second-Line Preventive Options:
- Cyproheptadine: Often used in younger children due to liquid formulation 3
- Flunarizine (5 mg/day): Likely effective based on available data 4
Important Considerations:
- Discuss with patients/families that placebo response is high in pediatric migraine trials 1
- For females of childbearing age, discuss teratogenic effects of topiramate and valproate; recommend effective birth control and folate supplementation 1
- Avoid divalproex, onabotulinumtoxinA, and nimodipine due to insufficient evidence of benefit 1
Non-Pharmacologic Approaches
These should be implemented alongside pharmacologic treatments:
- Lifestyle modifications:
- Regular sleep schedule
- Adequate hydration
- Regular meals and exercise
- Stress management 3
- Trigger identification and avoidance 1
- Cognitive behavioral therapy 3
- Biofeedback 3
- Magnesium supplementation: Relatively few adverse effects with good evidence for symptom improvement 3
Clinical Pearls and Pitfalls
- The high placebo response in pediatric migraine trials (up to two-thirds of patients) complicates evidence-based treatment 1, 5
- Combination therapy (medication plus behavioral interventions) is often more effective than medication alone 3
- Medication overuse can worsen headache patterns; monitor frequency of acute medication use
- Consider comorbidities when selecting preventive medications (e.g., avoid propranolol in asthmatic patients) 3
- Early intervention with both acute and preventive treatments leads to better outcomes and improved quality of life 6
Remember that approximately two-thirds of pediatric migraine patients improve with standard therapy, but for the remaining third (about 3% of all children), more aggressive and individualized approaches may be necessary to prevent suffering and disability 1.